From the research done on the deafferented monkeys, two signature components of Constraint Induced therapy were derived: intense training in the laboratory of the affected limb, and restraint of the non affected limb. A third component was later added when therapy began with humans in order to enforce the use of the restraint in the home.
It included instruction on behavioral techniques, such as keeping a journal, to help transfer learning to real life. Uswatte, Taub, Morris, Barmen, and Crago (2006) looked more closely at the components, or treatment techniques, of Constraint Induced therapy and compared it to treatment outcome. The goal was to determine the importance of each component in order to make treatment more efficient and cost effective. Uswatte et al (2006) used four interventions on four treatment groups: Sling and Shaping, Sling and Task Practice, Half-glove and Shaping, and Shaping Only. The three groups that required restraint were asked to wear their restraint 90% of waking hours.
Seventeen participants affected by stroke greater then one year ago participated in the study. The Sling and Shaping group had their unaffected side restrained using a hand splint and sling and were treated using shaping tasks. Shaping is a treatment technique that includes performing tasks such as spooning beans or blocks to a box. The tasks increase in difficulty as performance improves and frequent feedback is given immediately. The Sling and Task Practice Group was restrained the same way, but were treated using Task Practice in which they performed real-life tasks such as eating, throwing a ball, or pushing a broom. They were not given explicit feedback but were given encouragement. The Half-glove and shaping group used a glove with the fingers cut out on the affected side, and treated using shaping tasks. This type of restraint does not physically restrain the participant, but acts as a reminder to avoid use of the 3 unaffected side. The benefit of this type of restraint is that patients with poor balance can still have a mobile extremity to balance themselves. Patients with poor balance are not recommended for constraint induced therapy with a sling. The last group was treated using shaping only and was not restrained, but was encouraged to avoid use of the unaffected side. Treatment outcomes were assessed using two types of mobility.
Spontaneous use in the real-world was measured with the Motor Activity Log (MAL).
The MAL measures the quality as well as the quantity in which the person uses the affected side. The Wolf Motor Function Test was used to measure motor skills on demand. This test measures quality of movement as well as performance time by performing 15 timed tasks using there affected arm.
The results of this study showed that participants in all four groups demonstrated improvement from pre to post test immediately after and also one month after the treatment. There were no significant differences among outcomes among the four groups. However, when tested two years after treatment, Sling and Task Practice appeared to have slightly better progress then Sling and Shaping. Sling and Shaping had slightly better progress then Half-Glove and Shaping.
These results suggested that Shaping and Task Practice could be equivalent methods of treatment. Because the Task Practice Method does not require as much supervision or feedback and can be practiced on functional tasks in the home, it could be a more cost-effective form of treatment. It is noted that immediately after training there did not seem to be much difference between the groups, suggesting that perhaps physically restraining the patient is not necessary. However after the two year follow up, the gloved participants had less improvement then the participants restrained with a sling, suggesting that for long term retention the restraints could be beneficial.
Prior to the use of constraint induced therapy, physical therapy attempts had little effect on individuals with chronic stroke and upper extremity dysfunction more than one year post stroke. A study was done by to determine the efficacy of constraint induced therapy for treating individuals with chronic stroke and to determine its long term benefits.
The participants consisted of 41 individuals with chronic stroke. They were placed in either a constraint induced therapy group, or control group treated with a placebo. The groups were blocked based on prior level of function as tested by the Wolf Motor Function test. The group that received constraint induced therapy had the unaffected limb restrained in a sling, in combination with intense shaping therapy of the affected limb. The control group was treated using a general fitness program to promote strength, balance, and endurance. Both groups were trained for six hours a day for two weeks.
Progress was measured in a real-world setting using the Motor Activity Log. The Wolf Motor Function test, using a 5 point scale, was used to measure performance time as well as functional mobility. The participants were tested immediately post treatment, four weeks post treatment, and again two years later. Immediately after treatment scores for the therapy group had improved from pretest scores by 1.9 points, compared to .1 points for the control group. Four weeks post treatment the therapy group maintained 1.8 points above their pretreatment scores, and the control group had little change. Two years post treatment, participants who received constraint induced therapy maintained a higher functional level with scores 1 point higher then pretest scores.
This study suggests that CI therapy is an effective treatment for stroke when compared to a conservative therapy program, that chronic stroke patients can still show improvements in functional mobility even if it's been greater then a year post stroke, and that progress can be maintained well after treatment.
Constraint Induced Therapy to Treat Subacute vs. Chronic Stroke
When treating individuals with stroke using constraint induced therapy, it is important to know the appropriate time in their recovery to initiate treatment. The next two articles address the effects of constraint induced therapy in early stroke rehabilitation, and the effects three to nine months after stroke. Boake et al. (2007) performed a study on constraint induced therapy in stroke patients within the first two weeks after stroke. Prior to this study there was evidence that constraint induced therapy was beneficial for chronic stroke patients more than one year after stroke, but very little research had done on constraint induced therapy with early stroke. The researchers hoped to determine whether this type of treatment was feasible in a subacute setting, to determine if learned non-use could be prevented, and to determine if functional improvements were long term. They also measured and compared the neurophysiologic change with therapeutic gains by using transcranial magnetic stimulation (TMS).
The participants consisted of 23 stroke patients, all within two weeks after their stroke, who had upper extremity weakness. They were placed in a group treated with constrain induced therapy or a control group treated with conservative physical therapy.
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The constraint induced therapy group received treatment that consisted of restraining the unaffected side using a padded mitt, along with shaping tasks for the affected side. The control group was treated using traditional therapy that consisted of performing activities of daily living along with therapeutic exercise of the affected limb to improve range of motion and strength. Both groups received therapy for up to 3 hours a day for 14 to 15 days. Outcomes were measured using the Fugl-Meyer Assessment of Motor Recovery, the Grooved Pegboard Test, and the Motor Activity Log, along with TMS during treatment times to determine neurophysiologic changes. The Fugl-Meyer Assessment
Test was used to test motor performance. The Grooved Pegboard Test was used to test manual dexterity. The Motor Activity Log was used to determine the quantity and the quality of movement. TMS is a way of mapping the motor threshold in the hand motor area of each cerebral hemisphere in order to compare brain activity with physical progress. The patients were tested immediately following therapy as well as three to four months after their stroke.
The results immediately following treatment showed that overall motor improvements throughout all tests were slightly greater in the constraint induced therapy group compared to the control group, however the improvement between groups was not statistically significant. When tested again three to four months after stroke, both groups had made gains on the Fugl-Meyer and Pegboard tests but the difference between them was not statistically significant. The Motor activity log showed overall better improvement in quality of movement for the constraint induced therapy group, but no improvement for how often they used their affected upper extremity. The TMS results showed an overall increase in motor activity in the brain for both groups, but no difference in motor threshold between the therapy and control groups.
These results show that using constraint induced therapy in the early stages of stroke when compared to traditional therapy has little difference on the overall outcome in motor movements. However the researchers point out that there were no adverse affects of using constraint induced therapy in the subacute setting. I think it's worthy to note that the duration of treatment, three hours a day in this study, was shorter then the six hours spent in previous studies done on more chronic stroke patients. This could have an effect on functional outcomes. It may have been beneficial to measure the groups further out to determine if there are any long term benefits of using constraint induced therapy when used in the earlier stages of stroke. Steven et al. (2006) performed a large nationwide study on the effect of constraint induced therapy three to nine months after stroke. This is the time frame in which traditional therapy techniques are usually complete and the likelihood for spontaneous recovery has decreased. The researchers hypothesized patients who received constraint induced therapy up to nine months after stroke would have more gains than patients who received traditional care.
The study was carried out over seven clinical sites. Two hundred and twenty-two patients who had had a stroke within the last three to nine months and had limited upper extremity function participated in the study. They were separated into a control group and a group that received constraint induced therapy. The control group received continued traditional care such as orthotics, outpatient physical or occupational therapy, and outpatient hospital visits. The constraint induced therapy group wore a mitt on the 8 unaffected side for 90% of the time and were treated for up to 6 hours a day for two weeks. They were treated using shaping tasks and standard (more functional) tasks.
Compliance to wear the mitt at home was encouraged and reinforced using a behavioral contract along with other behavioral techniques.
The motor outcomes were measured using the Wolf Motor Function Test, and movement quantity and quality was measured using the Motor Activity Log given to both the participant and the caregiver. Participants were measured at base line through twelve months. Overall results showed larger improvements for the constraint induced therapy group compared to the control group for post treatment testing. The constraint induced therapy group continued to show better performance than the control when tested at four, eight, and twelve months. These results suggest that constraint induced therapy is beneficial when performed three to nine months after stroke and that results are maintained for at least a year. I think the most important observation is that gains can be made after the initial three months and well into then next year even after chance of spontaneous recovery is low.
When looking at the last three studies, it seems that there is good evidence that constraint induced therapy is beneficial for treating the upper extremity in patients with stroke. More gains seem to be made using this technique three months or more after stroke when compared to traditional therapy in the earlier stages of rehabilitation, and treatment can continue to be used even if the stroke event was more than one year prior.
Constraint Induced Therapy in Pediatrics
Because constraint induced therapy appeared to be beneficial in treating stroke, other studies were done to determine if it could also be applicable to pediatrics. Taub, Ramey, DeLuca, and Echols (2004) performed a study to determine the efficacy of constraint induced therapy for children with Cerebral Palsy. Cerebral Palsy is defined as a non-progressive motor impairment syndrome caused by a problem in the developing brain (Pellegrino, as cited in Ramey et al., 2004) . Prior to Constraint Induced Therapy, the efficacy of conservative physical therapy when treating children with cerebral palsy was questionable. The purpose of the study was for researchers to compare treating children with Constraint Induced Therapy or with conservative therapy to determine if it can improve motor function.
Eighteen children with Cerebral Palsy between the ages of 7 months to 8 years were in the study. All had hemiparesis or substantial motor deficits in one upper extremity. They were tested prior to assignment of groups to ensure there were no substantial differences in age, gender, or severity of hemiparesis, and then placed in either the Pediatric Constraint Induced Therapy group or the control group. Pediatric Constraint Induced Therapy uses two similar components of Constraint Induced Therapy used in adults: constraint, and intense therapy using shaping techniques. They constrained the children using a lightweight fiberglass cast. Pediatric versus traditional Constraint Induced Therapy is unique in that it allows for treatment in the home, parental involvement, and tasks adapted for children (Deluca, Echols, Law, & Ramey, 2006) The constraint group was treated for 6 hours of therapy per day for 21 days. The control group was treated using conservative physical and occupational therapy techniques for an average of 2.2 hours a week.
Progress was tested using three measures: the Emerging Behaviors Scale (EBS), the Pediatric Motor Activity Log (PMAL), and the Toddler Arm use Test (TAUT). The EBS was created during this study to measure and score the number of new behaviors exhibited by a child after treatment began, but that had never before been performed by the child prior to treatment. It was scored on 31 behaviors such as reaching, carrying or releasing objects, various transfers (sit to crawl, crawl to stand), and hand gestures. The PMAL is the Motor Activity Log adapted for use with children. The child's caregiver was interviewed to evaluate how well and how often the child used their affected upper extremity based on 22 functional activities of young children. The PMAL was scored on a scale from 0-5. The TAUT is a more standardized lab test of 22 task/play activities.
The children were tested before and after treatment once the cast was removed. They were scored on whether they would initiate movement to perform the task with their affected or non-affected upper extremity.
After treatment a mean of 9.3 new behaviors on the EBS were observed in the Constraint Induced Therapy group compared to the control group who had a mean of 2.2 new behaviors. The PMAL showed more improvement pre to posttreatment in the Constraint Induced Therapy group with increased scores by 2.1 points for the amount of use and 1.7 for the quality of use. The Control had increased scores of 0.1 and 0.3. Performance on the TAUT showed an increased initiation of movement from pre to posttreatment by 53.9% compared to the control group who increased by 18%. Follow up was done at three and six months using the PMAL and children maintained scores from posttreatment. These scores showed that significant gains were made using Constraint Induced therapy compared to conservative therapy techniques and that these score were maintained at three and six weeks. This shows that Constraint Induced therapy may be adaptable to children and may be as effective in treating children as it is for adults. It is important to note that because the control group only received 2.2 hours of training a week compared to the six hours of training a day the Constraint Induced Therapy group received, it is hard to determine if more gains were made from the casting, the intense training, or a combination of the two.
A similar study was performed by Deluca, Echols, Law, and Ramey (2006) to again compare Constraint Induced Therapy with controlled conservative therapy for children with Cerebral Palsy. However this study was randomized and done in two phases. In the first phase the participants were assigned randomly to either the control group or to the Constraint Induced Therapy group. The participants included 18 children with cerebral palsy between the ages of 7 months to 8 years. The Constraint Induced Therapy group again used casting and intense therapy while the control group continued with their previous physical or occupational therapy program. In the second phase, the control group was crossed over to receive Constraint Induced Therapy using the same protocol as the initial Constraint Induced Therapy group. The initial Constraint Induced Therapy group continued follow-up testing during this phase.
Progress was measured using the Upper Extremity Skills Test and the PMAL.
The Upper Extremity Skills Test measures upper extremity movement disorders in four domains: dissociated movements, grasp, protective extension, and weight bearing. In phase one, results for both tests showed significant gains in the Constraint Induced Therapy group compared essentially no gain in the Control group. In phase two, the initial Constraint Induced Therapy group maintained their gains at follow-up. After receiving Constraint Induced Therapy the control group made significant gains compared to pretreatment.
The results of the last two studies allow us to suggest that Constraint Induced Therapy is beneficial in treating children with Cerebral Palsy. It does leave in question however, which components of Pediatric Constraint Induced Therapy are contributing the most, and whether or not it can be used in other pediatric populations with motor deficits.
Studies could still be done that include later follow-up to determine maintained gains further out. If Pediatric Constraint Induced Therapy is used at any particular age, could it have an affect on development later on? There is still much to be studied in terms of Pediatric Constraint Induced Therapy.
In this review I have covered the history of Constraint Induced Therapy and it's beginning with Monkeys. I have looked at the treatment components of both traditional and pediatric Constraint Induced Therapy. It was then used to treat humans with stroke and children with cerebral palsy, and found to be efficacious when traditional therapy was providing little gains. Another study could be done to determine which treatment components are contributing most to progress and could they be combined with more traditional techniques such as shorter more realistic treatment durations. It would also be beneficial to study Constraint Induced Therapy applied to other populations and other mot or deficits.
